MedTrace Logo

Evaluation of a Combined Parent-student Programme for Smoking Prevention in Berlin Schools

NCT01306552 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3400

Last updated 2011-03-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of a combined parent-student program for smoking prevention in 7th graders in Berlin schools.

Conditions

  • Tobacco Use Disorder

Interventions

BEHAVIORAL

Student-Intervention only group

One visit to the smoking prevention parcours offered by KARUNA e.V. ("Rauchst Du noch oder lebst Du schon?") during 7th grade. The parcours takes approximately 3 hours to complete. The parcours consists of 7 interactive stations where a class of students learns about differences between smokers and non-smokers in terms of health status such as atherosclerosis prevalence, loss of smell or lung capacity and aging. Students also learn about the toxic ingredients in cigarettes. Each station includes a quiz to complete by each group of students. At the end of the parcours, a moderator will announce which group of students accumulated the most points. For more information on the contents of the parcours see http://www.karuna-prevents.de/index.php.

BEHAVIORAL

Multi-component Intervention

One visit to the smoking prevention parcours offered by KARUNA e.V. ("Rauchst Du noch oder lebst Du schon?") + one parent night with information about smoking prevention and one informational letter by mail

BEHAVIORAL

Control Group

One visit to the Nutrition and Physical Activity Parcours offered by KARUNA e.V. ("Kinderleicht gesund zu leben"). (same set up as the smoking prevention parcours with topics around healthy nutrition and promotion of physical activity)

Sponsors & Collaborators

  • Senatsverwaltung für Bildung, Wissenschaft und Forschung, Berlin, Germany

    collaborator UNKNOWN

  • KARUNA prevents, Berlin, Germany

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Stefan N Willich, MD · Charité University Medical Center, Institute for Social Medicine, Epidemiology and Health Economics

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01306552 on ClinicalTrials.gov